CONCLUSION: Under assumptions that are very favorable to screening, continuing to screen for cancer beyond 80 years of age does not appear to be cost-effective. Although screening for breast and colon cancer in 70 ± 79 year olds may be cost-effective, the gains in life expectancy are small and may be outweighed by potential harms.